Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

University of British Columbia

$818,550.00

Genetic mapping of a stress response and pro-longevity network in C. elegans and human cancer cells

EF 2022-23

Résumé
Advanced age is a major risk factor for many diseases, including cancers and neurodegenerative diseases such as Parkinson's disease. In our body's cells, damage accumulates as we age, and this is thought to be a key cause of these diseases and of aging itself. There are cellular processes that protect against such damage, and turning them on might prevent both aging and age-associated diseases. Our lab identifies and maps these processes, commonly referred to as stress responses. In the lab, we can study stress responses in a small roundworm, which lives only 20-30 days and shares many genes with us humans; this makes it an ideal animal in which to model aging and age-associated diseases. Using this approach, we discovered a new pathway by which cells respond to stresses; this pathway also staves off aging. Moreover, we also studied this pathway in human cancer cells and found that there, too, it may protect cells from damaging cellular stress. In the current project, we will (a) map genes that activate the stress response pathway we discovered; (b) find out which biological processes are activated by the new pathway to keep animals healthy as they age; and (c) study if the human analog of one of the worm genes protects human lung cancer cells from stress and whether blocking this pathway can therefore be used to destroy cancerous cells. We anticipate that our research will reveal new molecules that may be used to treat some age-associated diseases, such as cancers.
Programme
Project Grant
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
469325
Name
Taubert Stefan
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Biomedical
Prcname2
Biological and Clinical Aspects of Aging
Projecttitle
Genetic mapping of a stress response and pro-longevity network in C. elegans and human cancer cells
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$818,550
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
C. Elegans; Cancer Cell Lines; Gene Regulation; Hypoxia; Longevity; Mediator Complex; Oxidative Stress; Starvation; Transcription; Transcription Factors
Abstract
Advanced age is a major risk factor for many diseases, including cancers and neurodegenerative diseases such as Parkinson's disease. In our body's cells, damage accumulates as we age, and this is thought to be a key cause of these diseases and of aging itself. There are cellular processes that protect against such damage, and turning them on might prevent both aging and age-associated diseases. Our lab identifies and maps these processes, commonly referred to as stress responses. In the lab, we can study stress responses in a small roundworm, which lives only 20-30 days and shares many genes with us humans; this makes it an ideal animal in which to model aging and age-associated diseases. Using this approach, we discovered a new pathway by which cells respond to stresses; this pathway also staves off aging. Moreover, we also studied this pathway in human cancer cells and found that there, too, it may protect cells from damaging cellular stress. In the current project, we will (a) map genes that activate the stress response pathway we discovered; (b) find out which biological processes are activated by the new pathway to keep animals healthy as they age; and (c) study if the human analog of one of the worm genes protects human lung cancer cells from stress and whether blocking this pathway can therefore be used to destroy cancerous cells. We anticipate that our research will reveal new molecules that may be used to treat some age-associated diseases, such as cancers.
Competitiondate
202209
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Taubert, Stefan
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $818,550~ $0~